|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 5/0783 | (2010.01) |
| A61K 35/17 | (2015.01) |
| (11) | Number of the document | 3532607 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17798045.5 |
| Date of filing the European patent application | 2017-10-26 | |
| (97) | Date of publication of the European application | 2019-09-04 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-31 |
| (46) | Date of publication of the claims translation | 2024-05-10 |
| (86) | Number | PCT/US2017/058610 |
| Date | 2017-10-26 |
| (87) | Number | WO 2018/081473 |
| Date | 2018-05-03 |
| (30) | Number | Date | Country code |
| 201662413387 P | 2016-10-26 | US | |
| 201662413283 P | 2016-10-26 | US | |
| 201662415452 P | 2016-10-31 | US |
| (72) |
FRANK, Ian , US
LOTZE, Michael, T. , US
|
| (73) |
Iovance Biotherapeutics, Inc. ,
825 Industrial Road
Suite 400, San Carlos, CA 94070,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kriokonservuotų naviką infiltruojančių limfocitų restimuliacija |
| RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES |
| Payment date | Validity (years) | Amount | |
| 2024-10-21 | 8 | 185.00 EUR |
| 2025-10-26 |